Literature DB >> 7412776

Carnitine levels in normal children and adults and in patients with diseases muscle.

H N Carrier, G Berthillier.   

Abstract

An assay for evaluating carnitine levels in normal children and adults is described. After a 12-hour period of fasting, individual variations in 24-hour urinary excretion of carnitine were observed in adults. In children, there was a significant decrease in excretion from the 10th month to the third year, and then an increase until the 10th year. There was no significant difference between children and adults in the serum and skeletal muscle levels. Muscle carnitine levels were also studied in 12 cases of lipid-storage myopathy and in cases of other muscle diseases, including Duchenne muscular dystrophy in children.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7412776     DOI: 10.1002/mus.880030409

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  The effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibition on tissue levels of carnitine and carnitine acyltransferase activity in the rabbit.

Authors:  J Bhuiyan; D W Seccombe
Journal:  Lipids       Date:  1996-08       Impact factor: 1.880

Review 2.  [Rhabdomyolysis and myoglobinuria].

Authors:  A Lindner; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

3.  Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency.

Authors:  W Ruitenbeek; P J Poels; D M Turnbull; B Garavaglia; R A Chalmers; R W Taylor; F J Gabreëls
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

4.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Fatal lipid storage myopathy with deficiency of cytochrome-c-oxidase and carnitine. A contribution to the combined cytochemical-finestructural identification of cytochrome-c-oxidase in longterm frozen muscle.

Authors:  J Müller-Höcker; D Pongratz; T Deufel; J M Trijbels; W Endres; G Hübner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

6.  Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol.

Authors:  F Cornelio; F Dworzak; L Morandi; E Fedrizzi; M R Balestrini; L Gondoni
Journal:  Ital J Neurol Sci       Date:  1982-12

7.  Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome.

Authors:  I Bernardini; W B Rizzo; M Dalakas; J Bernar; W A Gahl
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

8.  Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment.

Authors:  N Bresolin; L Freddo; V Tegazzin; L Bet; M Armani; C Angelini
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

9.  Carnitine plasma concentrations in 353 metabolically healthy children.

Authors:  E Schmidt-Sommerfeld; D Werner; D Penn
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

Review 10.  Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.

Authors:  Emma Rybalka; Cara A Timpani; Christos G Stathis; Alan Hayes; Matthew B Cooke
Journal:  Nutrients       Date:  2015-11-26       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.